Ergoteles LLC Horizon Therapeutics Public LTD CO Call Options Transaction History
Ergoteles LLC
- $68.2 Billion
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HZNP
# of Institutions
38Shares Held
2.07MCall Options Held
0Put Options Held
20K-
Pictet Asset Management Sa Geneva 73, V8735KShares$00.09% of portfolio
-
Rothschild & CO Asset Management Us Inc. New York, NY404KShares$00.7% of portfolio
-
Jefferies Group LLC New York, NY237KShares$00.14% of portfolio
-
Regent Investment Management LLC101KShares$03.09% of portfolio
-
Berry Street Capital Management LLP London, X087.5KShares$02.97% of portfolio
About Horizon Therapeutics Public Ltd Co
- Ticker HZNP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 230,384,000
- Description
- Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...